Ocular tuberculosis – A closer look to an increasing reality

Autor: F. Teixeira-Lopes, S. Alfarroba, A. Dinis, M.C. Gomes, A. Tavares

Publikováno v: Pulmonology, Vol 24, Iss 5, Pp 289-293 (2018)

Introduction: Ocular tuberculosis (OTB) is a rare form of tuberculosis. Diagnosis is usually presumptive based on epidemiology, clinical findings and positivity of immune response. The aim of the study was to characterize the OTB cases identified in

Externí odkaz: https://doaj.org/article/e366b1a3144f4e27aee755446e1a2411

Experiência clínica com omalizumab na consulta de asma grave

Autor: S. Alfarroba, W. Videira, C. GalvãoâLucas, F. Carvalho, C. Bárbara

Publikováno v: Revista Portuguesa de Pneumologia, Vol 20, Iss 2, Pp 78-83 (2014)

Resumo: Introdução: Está bem documentado que o controlo de asma nem sempre é possível em doentes com asma grave apesar da terapêutica otimizada. O objetivo deste estudo foi avaliar a eficácia de omalizumab no controlo de asma com

Externí odkaz: https://doaj.org/article/f3f1b007d76b470d99755086eb51721d

Ocular tuberculosis – A closer look to an increasing reality

Autor: S. Alfarroba, A. Dinis, M.C. Gomes, A. Tavares, F. Teixeira-Lopes

Publikováno v: Pulmonology, Vol 24, Iss 5, Pp 289-293 (2018)

Introduction: Ocular tuberculosis (OTB) is a rare form of tuberculosis. Diagnosis is usually presumptive based on epidemiology, clinical findings and positivity of immune response. The aim of the study was to characterize the OTB cases identified in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34ea6213516aae163b132d926cb5ec2b
http://www.sciencedirect.com/science/article/pii/S2531043718300424

Clinical experience with Omalizumab in a Portuguese severe asthma unit

Autor: S. Alfarroba, Cristina Bárbara, F. Carvalho, C. Galvão‐Lucas, W. Videira

Publikováno v: Revista Portuguesa de Pneumologia (English Edition), Vol 20, Iss 2, Pp 78-83 (2014)

Background: It is widely recognized that asthma control is not always possible in patients with very severe asthma despite available treatment. The aim of this study was to evaluate the efficacy of Omalizumab on asthma control as an addâon therapy i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::537b92672b290a8c4b279bed12c6a638
http://www.sciencedirect.com/science/article/pii/S2173511514000207

Immune Checkpoint Inhibitor-Associated Myocarditis: A Rare Presentation With Atrioventricular Block and Sinus Node Dysfunction.

Autor: Cardoso I; Cardiology Service, Santa Marta Hospital, Central Lisbon Hospital and University Centre, Lisbon, Portugal., Ferreira VV; Cardiology Service, Santa Marta Hospital, Central Lisbon Hospital and University Centre, Lisbon, Portugal., Guerreiro I; Oncology Service, Central Lisbon Hospital and University Centre, Lisbon, Portugal., Alfarroba S; Oncology Service, Central Lisbon Hospital and University Centre, Lisbon, Portugal., Winckler P; Oncology Service, Central Lisbon Hospital and University Centre, Lisbon, Portugal., Mano T; Cardiology Service, Santa Marta Hospital, Central Lisbon Hospital and University Centre, Lisbon, Portugal., Morais L; Cardiology Service, Santa Marta Hospital, Central Lisbon Hospital and University Centre, Lisbon, Portugal., Thomas B; Heart Center, Cruz Vermelha Portuguesa Hospital, Lisbon, Portugal., Ferreira RC; Cardiology Service, Santa Marta Hospital, Central Lisbon Hospital and University Centre, Lisbon, Portugal.

Publikováno v: CJC open [CJC Open] 2023 Sep 09; Vol. 5 (11), pp. 829-832. Date of Electronic Publication: 2023 Sep 09 (Print Publication: 2023).